BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19561323)

  • 1. Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
    Kumar S; Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Lentzsch S; Munshi N; Niesvizky R; San Miguel J; Ludwig H; Bergsagel L; Blade J; Lonial S; Anderson KC; Tosi P; Sonneveld P; Sezer O; Vesole D; Cavo M; Einsele H; Richardson PG; Durie BG; Rajkumar SV;
    Blood; 2009 Aug; 114(9):1729-35. PubMed ID: 19561323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.
    Bhutani D; Zonder J; Valent J; Tageja N; Ayash L; Deol A; Al-Kadhimi Z; Abrams J; Lum L; Ratanatharathorn V; Uberti J; Abidi MH
    Support Care Cancer; 2013 Sep; 21(9):2437-42. PubMed ID: 23591714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of novel therapies for the treatment of relapsed myeloma.
    Richardson PG; Hideshima T; Mitsiades C; Anderson KC
    J Natl Compr Canc Netw; 2007 Feb; 5(2):149-62. PubMed ID: 17335684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
    Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG
    Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatments in multiple myeloma: beyond optimal treatment.
    Harousseau JL
    Ann Oncol; 2008 Jul; 19 Suppl 5():v68-70. PubMed ID: 18611904
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel agents in the frontline management of multiple myeloma.
    Loong HH
    Hematol Oncol Stem Cell Ther; 2008; 1(4):201-9. PubMed ID: 20058474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and therapy of multiple myeloma.
    Palumbo A; Cerrato C
    Korean J Intern Med; 2013 May; 28(3):263-73. PubMed ID: 23682217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cure for multiple myeloma?].
    Harousseau JL
    Presse Med; 2006 Sep; 35(9 Pt 2):1288-90. PubMed ID: 16969322
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance treatment in multiple myeloma.
    Harousseau JL
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv54-5. PubMed ID: 18519405
    [No Abstract]   [Full Text] [Related]  

  • 10. (Bortezomib plus lenalidomide/thalidomide)- vs. (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.
    Wang A; Duan Q; Liu X; Ding K; Han Y; Zhu W; Cai X; Wu J; Sun Z
    Ann Hematol; 2012 Nov; 91(11):1779-84. PubMed ID: 22773209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma: novel approaches for relapsed disease.
    Lonial S
    Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 1():S18-23. PubMed ID: 18282362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent progress in diagnosis of and therapy for multiple myeloma].
    Okamoto S
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1922-31. PubMed ID: 17037337
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of newly diagnosed multiple myeloma.
    Palumbo A; Magarotto V; Larocca A; Bringhen S; Falco P; Di Raimondo F; Baldini L; Boccadoro M
    Curr Hematol Malig Rep; 2008 Apr; 3(2):107-14. PubMed ID: 20425454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
    Kettle JK; Finkbiner KL; Klenke SE; Baker RD; Henry DW; Williams CB
    J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapies in the treatment of multiple myeloma.
    Laubach JP; Mitsiades CS; Mahindra A; Schlossman RL; Hideshima T; Chauhan D; Carreau NA; Ghobrial IM; Raje N; Munshi NC; Anderson KC; Richardson PG
    J Natl Compr Canc Netw; 2009 Oct; 7(9):947-60. PubMed ID: 19878638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current multiple myeloma treatment strategies with novel agents: a European perspective.
    Ludwig H; Beksac M; Bladé J; Boccadoro M; Cavenagh J; Cavo M; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Harousseau JL; Hess U; Ketterer N; Kropff M; Mendeleeva L; Morgan G; Palumbo A; Plesner T; San Miguel J; Shpilberg O; Sondergeld P; Sonneveld P; Zweegman S
    Oncologist; 2010; 15(1):6-25. PubMed ID: 20086168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of novel agents in the treatment of relapsed and refractory multiple myeloma.
    Laubach JP; Mahindra A; Mitsiades CS; Schlossman RL; Munshi NC; Ghobrial IM; Carreau N; Hideshima T; Anderson KC; Richardson PG
    Leukemia; 2009 Dec; 23(12):2222-32. PubMed ID: 19741729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part I: the role of maintenance therapy in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
    McCarthy PL
    J Natl Compr Canc Netw; 2013 Jan; 11(1):35-42. PubMed ID: 23307979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and management guideline for multiple myeloma].
    Murakami H; Handa H; Saitoh T
    Nihon Rinsho; 2007 Dec; 65(12):2167-76. PubMed ID: 18069257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.
    Benson DM; Panzner K; Hamadani M; Hofmeister CC; Bakan CE; Smith MK; Elder P; Krugh D; O'Donnell L; Devine SM
    Leuk Lymphoma; 2010 Feb; 51(2):243-51. PubMed ID: 20038230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.